Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 18, Issue 1, 2000, Pages 122-130

  Sandler, Alan B ^a   Nemunaitis, J ^a   Denham, C ^a   Von Pawel, J ^a   Cormier, Y ^a   Gatzemeier, U ^a   Mattson, K ^a   Manegold, Ch ^a   Palmer, M C ^a   Gregor, A ^a   Nguyen, B ^a   Niyikiza, C ^a   Einhorn, L H ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; GEMCITABINE;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INCIDENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUTROPENIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE;

EID: 17344384668     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.2000.18.1.122     Document Type: Article

References (28)

1. Ginsberg RJ, Kris MG, Armstrong JG: Cancer of the lung, in DeVita VT, Hellman S, Rosenbert SA (eds): Cancer: Principles and Practice of Oncology (ed 4). Philadelphia, PA, JB Lippincott, 1993, pp 673-723
2. Holmes EC, Livingston R, Turrissi A III: Neoplasms of the thorax, in Holland JF, Frei E III, Bast RC Jr, et al (eds): Cancer Medicine (ed 3). Philadelphia, PA, JB Lippincott, 1993, pp 1285-1337
3. Cellerino R, Tummarello D, Guidi F, et al: A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. J Clin Oncol 9:1453-1461, 1991
4. Ganz P, Figlin R, Haskell C, et al: Supportive care versus supportive care and combination chemotherapy in metastatic non-small cell lung cancer. Cancer 63:1271-1278, 1989
5. Rapp E, Pater JL, Willan A, et al: Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer: Report of a Canadian multicenter randomized trial. J Clin Oncol 6:633-641, 1988
6. Quoix E, Dietemann A, Charbonneau J, et al: Is chemotherapy with cisplatin useful in non-small cell bronchial cancer at staging IV? Results of a randomized study. Bull Cancer (Paris) 78:341-346, 1991
7. Woods R, Williams C, Levitt J, et al: A randomized trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. Br J Cancer 61:608-611, 1990
8. Stewart LA, Pignon J-P, Pamar MKB, et al: A meta-analysis using individual patient data from randomized clinical trials (RCTS) of chemotherapy (CT) in non-small cell lung cancer (NSCLC): Survival in the supportive cancer (SC) setting. Proc Am Soc Clin Oncol 13:337, 1994 (abstr 1118)
9. Feigal EG, Christian M, Cheson B, et al: New chemotherapeutic agents in non-small cell lung cancer. Semin Oncol 20:185-201, 1993
10. Hertel LW, Kroin JS, Misner JW, et al: Synthesis of 2-deoxy-2',2'-difluoro-D-ribose and 2-deoxy-2',2'-difluoro-D-ribofuranosyl nucleosides. J Org Chem 53:2406-2409, 1998
11. Anderson H, Thatcher N, Walling J, et al: Gemcitabine and palliation of symptoms in non-small-cell lung cancer. Proc Am Soc Clin Oncol 13:367, 1994 (abstr 1238)
12. Negoro S, Fukuoka M, Kurita Y, et al: Results of Phase II studies of gemcitabine in non-small-cell lung cancer (NSCLC). Proc Am Soc Clin Oncol. 13:367, 1994 (abstr 1239)
13. Shepherd FA, Gatzemeier U, Gotfried M, et al: An extended phase II study of gemcitabine in non-small-cell lung cancer (NSCLC). Proc Am Soc Clin Oncol 12:330, 1993 (abstr 1096)
14. Abratt RP, Bezwoda WR, Falkson G, et al: Efficacy and safety profile of gemcitabine in non-small-cell lung cancer: A phase II study. J Clin Oncol 12:1535-1540, 1994
15. Peters GJ, Bergman AM, Ruiz van Haperen VWT, et al: Schedule dependency of the synergism between the combination of cisplatin and gemcitabine in resistant A2780 human ovarian cancer cell lines. Ann Oncol 5:82, 1994 (suppl 5)
16. Braakhuis BJ, Ruiz van Haperen VWT, Bergman AM, et al: Preclinical in vivo evaluation of the combination of 2', 2'-difluorodeoxycytidine and cisplatin. Ann Oncol 5:82, 1994 (suppl 5)
17. Sandler AB, Ansari R, McClean J, et al: A Hoosier Oncology Group phase II study of gemcitabine plus cisplatin in non-small cell lung cancer. Cancer Ther 1:158-163, 1998
18. Crino L, Scagliotti G, Marangolo M, et al: Cisplatin-gemcitabine combination in advanced non-small-cell lung cancer: A phase II study. J Clin Oncol 15:297-303, 1997
19. Steward WP, Dunlop DJ, Cameron C, et al: Phase I/II study of cisplatin in combination with gemcitabine in non-small-cell lung cancer. Proc Am Soc Clin Oncol 14:351, 1995 (abstr 1064)
20. Abratt RP, Bezwoda WR, Goedhals L, et al: Weekly gemcitabine with monthly cisplatin: Effective chemotherapy for advanced non-small-cell lung cancer. J Clin Oncol 15:744-749, 1997
21. Cella DF, Bonomi AE, Lloyd SR, et al: Reliability and validity of the Functional Assessment of Cancer Therapy-Lung (FACT-L) quality of life instrument. Lung Cancer 12:199-220, 1995
22. Kaplan EL, Meier P: Nonparametric estimation of incomplete observations. J Am Stat Assoc 53:457-481, 1958
23. SAS/STAT User's Guide, Version 6 (ed 4), Vol 2. Cary, NC, SAS Institute Inc, 1989, p 846
24. Gandara DR, Crowley J, Livingston RB, et al: Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: A phase III study of the Southwest Oncology Group. J Clin Oncol 11:873-878, 1993
25. Klastersky J, Sculier JP, Bureau G: Cisplatin versus cisplatin plus etoposide in the treatment of advanced non-small-cell lung cancer. J Clin Oncol 7:1087-1092, 1989
26. Le Chevalier T, Brisgand D, Douillard J-Y, et al: Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: Results of a European multicenter trial including 612 patients. J Clin Oncol 12:360-367, 1994
27. Wozniak AJ, Crowley JJ, Balcerzak SP, et al: Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small-cell lung cancer. J Clin Oncol 16:2459-2465, 1998
28. von Pawel J, von Roemeling R: Survival benefit from Tirazone (tiripazamine) and cisplatin on advanced non-small-cell lung cancer patients: Final results from the international phase III CATAPULT-I trial. Proc Am Soc Clin Oncol 17:454a, 1998 (abstr 1749)